TNF and rheumatoid arthritis: If similar changes in pharmacodynamics occur in a subset of patients with RA, that is, that TNF-α ceases to contribute to inflammation after prolonged TNFi therapy, these patients might be in remission regardless of receiving sustained TNFi therapy.